Screening and identification of key biomarkers in diabetic kidney disease and its complications: Evidence from bioinformatics and next generation sequencing data analysis
Basavaraj Mallikarjunayya VastradiD, Chanabasayya Mallikarjunayya VastradiD
Abstract
Diabetic patients are prone to diabetic kidney disease (DKD), which may cause cardiovascular damage, hypertension and obesity, and reduce quality of life. As a result, the life quality of patients was seriously reduced. However, the pathogenesis of diabetic kidney disease (DKD) has not been fully elucidated, and current treatments remain inadequate. Therefore, it is essential to explore the molecular mechanism of DKD and its complications. Next Generation Sequancing (GSE217709) dataset was obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were picked out by R software. Then Gene ontology (GO) and REACTOME pathway enrichment analysis were performed by g:Profiler database, protein-protein interaction (PPI) of DEGs was constructed by Human Integrated Protein-Protein Interaction rEference (HIPPIE) database. Module analysis was carried out by Cytoscape plug-in PEWCC. Subsequently, miRNA-hub gene regulatory network and TF-hub gene regulatory network were performed by miRNet database and NetworkAnalyst database. Finally, validation of hub genes was performed by receiver operating characteristic (ROC) curve analysis to predict the diagnostic effectiveness of the hub genes. In total, 958 DEGs, including 479 up regulated and 479 down regulated genes, were identified. The GO and pathway enrichment changes of DEGs were mainly enriched in biological regulation, multicellular organismal process, signaling by GPCR and extracellular matrix organization. Ten hub genes (HSPA8, HSP90AA1, HSPA5, SDCBP, HSP90B1, VCAM1, MYH9, FLNA, MDFI and PML) associated with DKD and its complications were identified. Bioinformatics analysis is a useful tool to explore the molecular mechanism and pathogenesis of DKD and its complications. The identified hub genes may participate in the onset and development of DKD and its complications and serve as therapeutic targets.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cross-Domain Text Mining of Pathophysiological Processes Associated with Diabetic Kidney Disease
Krutika Patidar, Jennifer Deng, … Ashlee N. Ford Versypt·International Journal of Molecular SciencesPeer-reviewed·Apr 19, 2024
- Transcriptomic-Based Identification of FCRL6 as a Novel Diagnostic Biomarker in Diabetic Nephropathy
Adarsh Marinedrive, Sonalika Ray, Mohit Mazumder·bioRxiv·Nov 1, 2024
- Discovering hub genes involved in the pathophysiological impact of COVID-19 on diabetes kidney disease by differential gene expression and interactome analysis
Ulises Osuna‐Martínez, Katia Aviña‐Padilla, … Loranda Calderón-Zamora·bioRxiv·Oct 11, 2022
- Identification of novel prognostic targets in acute kidney injury using bioinformatics and next generation sequencing data analysis
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·bioRxiv·Mar 17, 2024
- Bioinformatics analysis of potential key genes and mechanisms in type 2 diabetes mellitus
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·bioRxiv·Mar 28, 2021
- Analysis of key genes and pathways associated with the pathogenesis of Type 2 diabetes mellitus
Varun Chandra Alur, Varshita Raju, … Shivakumar Kotrashetti·bioRxiv·Aug 12, 2021